Biomarkers, CDx & Precision Medicine 2026
.png)
13 - 14 October 2026
Congress Centre Basel, Switzerland
Congress Centre Basel, Switzerland
Enchi Liu
Vice President & Head Experimental Medicine,
Lundbeck
Guillaume Cettou
Executive Director Diagnostics,
GSK
Isabella Gashaw
Head of Experimental Sciences CRM,
Boehringer Ingelheim
Jennifer Tucker
Global Head of Regulatory Affairs, Pathology Lab,
Roche Tissue Diagnostics
Maciej Cabanski
Vice President Biomarkers and CDx,
Monte Rosa Therapeutics
Omar El Nahhas
Chief Executive Officer & Co-Founder,
StratifAI GmbH
Özlem Akilli
Director Department of Spatial Biology and Cellular Dynamics,
TRON Translational Oncology Mainz
Rene Kubiak
Global Head Early Development & Non-Clinical Biostatistics,
Sanofi
Svetlana Mukhina
Director Global Regulatory Affairs, CDx,
Merck Healthcare KGaA
Adisa Trnjanin
Co-Founder & Co-Head,
ZHAW Life Sciences
Aditi Deshpande
Director, Biology,
Bioage labs
Alberto Valdeolivas Urbelz
Principal Scientist,
Roche
Amela Jusic
Translational Research Lead,
Quant Biomarkers
Andreia Soares
Scientific Director,
Synexa Life Sciences
Bernhard Polzer
Head of Cellular and Molecular Diagnostics,
Fraunhofer Institute
Bogdan Munteanu
Lab Head Global Imaging Mass Spectrometry Biomarker Discovery Platform (DMPK),
Sanofi
Carsten Krantz
Associate Director,
Novartis
Catherine Gilbert
Field Application Scientist,
Seer
Céline Pallaud
Precision Medicine Strategy Head,
Novartis
Celine Vandamme
Director, Scientific Business Development,
CellCarta
Christoph Rohde
Head of Laboratory, Clinical Biomarkers & Technologies,
Merck Healthcare KGaA
David Fabrizio
VP, Commercial Strategy and Medical Innovation,
Foundation Medicine
David Klug
Professor of Chemical Biophysics, Department of Chemistry,
Imperial College London
David Latto
Associate Product Specialist Director ,
IQVIA Laboratories
Diego Saldana Miranda
Associate Director and Senior Data Scientist,
Novartis
Emmanouil Karteris
Professor in Biomedical Sciences,
Brunel University of London
Eric Letouzé
Head of Single Cell,
One Biosciences
Eshita Mutt
Senior Bioinformatics Support Scientist Proteomics Regional S&S,
Illumina
Espen Walker
Head of Global Medical Diagnostics,
AstraZeneca
Federico Pratesi
Senior Multiomics Sales Specialist,
Illumina
Florian Langer
Sales & Applications Manager,
Histomography GmbH
Gavin Gordon
SVP, Precision Medicine & Strategic Alliances,
Singular Genomics
Georgia Cresswell
Research Services Business Development Manager,
Patholytix
Heleen Verlinden
Senior Director,
Muna Therapeutics (K5)
Helene Fachim
Clinical Research Manager,
Cure Parkinson's
Inês Santarino
Business Development Manager,
Cyentia Biosource
Jacek Lukawy
Innovation Program Director, Translational Medicine Clinical Sciences and Innovation/NIBR,
Novartis
Jan Lukas Robertus
Honorary Associate Professor, Imperial College London and Head of Pathology Department,
Royal Brompton & Harefield NHS Foundation Trust
Janne Martikainen
Professor,
University of Eastern Finland
Jessica Apulei
Scientific Liaison Manager - EMEA,
Hologic Diagenode
Johan Luthman
Executive Vice President & Head R&D ,
Lundbeck
Karthikeyan Devaraju
Senior Scientist,
Cerba Research
Kathrin Heinzmann
Senior Biomarker Scientist,
Cancer Research UK
Kathrin Schlueter
Medical Affairs Manager,
BD
Kedar Natarajan
Professor,
Ashoka University
Krzysztof Kolmus
Principal Scientist,
Ingenix
Magda Meissner
Clinical Liquid Biopsy Lead,
Velindre University NHS Trust
Maham Ansari
Senior Director, IVD Regulatory,
Precision for Medicine
Marie-Christine Bakker
MD-Researcher in Medical Oncology,
UMC Utrecht
Megan O’Shaughnessy
Scientific Affairs Specialist,
ICON
Michael Rebhan
Associate Director,
Novartis
Michal Rosen Zvi
Head of AI for Drug Discovery and Translational Medicine,
Merck
Mirella El Khoury
Senior Field Application Scientist,
Quanterix
Miro Venturi
Chief Executive Officer,
DIAMANTE Healthcare Consulting
Nina Skorytchenko
Chief Executive Officer,
Avenna
Oskar Smrzka
Chief Executive Officer/CSO/Co-Founder,
Ablevia
Paolo Paganetti
Head of Clinical & Laboratory,
Tivenix SA
Patrick Weber
Sales Solution Specialist,
Leica Microsystems, Inc.
Paul Workman
Harrap Professor of Pharmacology and Therapeutics,
The Institute of Cancer Research, London
Petra Kukkaro
Global Biomarker Diagnostic Director,
Novartis
Philip Beer
Chief Scientific Officer,
Step Pharma
Pim French
Professor Molecular Biology of Gliomas,
Erasmus MC
Priyanka Dutta Passecker
Chief Business Officer,
CellPly
Rachel Agoglia
Manager, Global Pharma Applications & Bioinformatics,
Mission Bio
Raif Yuecel
Director, Centre for Life Science Technologies,
University of Exeter
-2c46af.jpeg?length=600&name=e1513840-59d0-4975-833e-c9f68481cd1c-2-11764368speaker_photo-Photo_Safia-Agueni-(1)-2c46af.jpeg)
Safia Agueni
Co-Founder,
Healthseed
Sam Cooper
Director Data/ML,
Engitix
Serena Bologna
Principal scientist,
FoRx Therapeutics
Simon Höllerer
Data Scientist,
Novartis
Stefanie Engler
Lab Manager,
University of Zurich
Sujana Sivapatham
Application Scientist,
Arcoris Bio
Susan Greenfield
Chief Executive Officer and Founder,
Neuro-Bio Ltd
Tatjana Crnogorac-Jurcevic
Professor of Molecular Pathology and Biomarkers,
Barts Cancer Institute, Queen Mary University of London
Taylor Jensen
Vice President, Head of Science Enterprise Oncology,
Labcorp
Thom Reuvers
Chief Operating Officer,
Methylomics BV
-d810fc.png?length=600&name=52bd0f32-a3e8-4c01-bd72-7856c0c92cd6-2-11764368speaker_photo-image-(68)-d810fc.png)
Tomas Dias
Chief Scientific Officer,
Mursla Bio
Torbjørn Furuseth
Chief Executive Officer & Co-Founder,
DoMore Diagnostics
Ujjwal Mukund Mahajan
Associate Professor,
National Institute of Pharmaceutical Education and Research (NIPER)
Vasudev Kantae
Associate Director,
AstraZeneca
Vihanga Pahalawatta
Director,
AbbVie
